BBA
KRON

Baker Bros. Advisors’s Kronos Bio KRON Stock Holding History

Baker Bros. Advisors’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,198,151
Closed -$1.94M – 109
2022
Q4 		$1.94M Sell
1,198,151
-341,465
-22% -$786K 0.01% 100
2022
Q3 		$5.16M Buy
+1,539,616
New +$6.95M 0.03% 78

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Baker Bros. Advisors's KRON Position: Q1 2023 in Review

Baker Bros. Advisors sold out of Kronos Bio (KRON) in Q1 2023, closing a stake of 1,198,151 shares — an estimated $1.94M sold.

Baker Bros. Advisors first reported a position in KRON in Q3 2022 and held it in 2 quarters. The position peaked at $5.16M in Q3 2022. 87 funds tracked by Wall St. Rank hold KRON as of Q1 2023.

  • Baker Bros. Advisors reported no remaining Kronos Bio position as of Q1 2023 after selling out during the quarter.
  • Baker Bros. Advisors sold 1,198,151 Kronos Bio shares in Q1 2023, an estimated $1.94M.
  • Baker Bros. Advisors first reported a position in Kronos Bio in Q3 2022 and held it in 2 quarters.
  • Baker Bros. Advisors's Kronos Bio position peaked at $5.16M in Q3 2022.
  • 87 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2023.

Based on Baker Bros. Advisors's 13F filing for Q1 2023, filed 15 May 2023.